Head and Neck Cancer Research Group
51 – 60 of 121
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Non-radical primary diagnostic biopsies affect survival in cutaneous head and neck melanoma
(
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
(
- Contribution to journal › Article
-
Mark
Mandibulotomy access to tumour sites : fewer complications for postoperative compared with preoperative radiotherapy
(
- Contribution to journal › Article
-
Mark
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
(
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
(
- Contribution to journal › Article
-
Mark
Transoral robotic surgery in the management of head and neck squamous cell cancer with unknown primary
(
- Contribution to journal › Article
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
-
Mark
Global RNA expression and DNA methylation patterns in primary anaplastic thyroid cancer
(
- Contribution to journal › Article
-
Mark
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer : Subgroup analysis of ARTSCAN-trial
(
- Contribution to journal › Article